-
MEI Pharma (MEIP) Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
-
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
-
MEI Pharma (MEIP) to Consider Strategic Alternatives
-
MEI Pharma to Consider Strategic Alternatives
-
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
-
MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights
-
MEI Pharma (MEIP) Initiates Strategic Realignment
-
MEI Pharma Initiates Strategic Realignment

